上次更新此網站的日期：
2014年01月02日

團隊成員-醫師團隊-洪志宏主任

洪志宏主任 Ji-Hong Hong M.D., Ph.D

學歷

Education

1984 台北醫學院醫學士畢業
1995 美國加州大學洛杉磯分校，生醫物理學博士 (Biomedical Physics) 畢業，主修輻射生物

9/1990 - 3/1995       Ph.D., Biomedical Physics Program, UCLA
9/1977 - 6/1984       M.D., Taipei Medical School

經歷

Academic appointment &Employment record

1984~1988 林口長庚醫院放射治療住院醫師訓練。
1988~1990 林口長庚醫院放射治療科主治醫師。
1990~1995 美國加州大學洛杉磯分校 生醫物理研究生
1995 美國加州大學洛杉磯分校醫學院射治療科博士後研究
1995~1997 林口長庚醫院放射治療科主治醫師
1995~ 長庚大學副教授
1997~1998 長庚大學醫技系放射組組主任
1997~ 林口長庚醫院放射腫瘤科主任
2004~長庚醫院教授級主治醫師、林口長庚醫院癌症中心副主任
2005~ 長庚大學教授
2010 ~林口長庚醫院癌症中心主任

Academic appointment:

8/1995 - Associate Professor, Chang Gung University
10/1997 – 1/1999    Director of Radiological Division, Department of Medical Technology, School of Medicine, Chang Gung University
7/1999-  Associate Professor Physician, Chang Gung Memorial Hospital
8/1999-  Associate Professor, Tsing Hwa University
7/2004   Professor Physician, Chang Gung Memorial Hospital
2/2005  Professor, Department of Medical Imaging and Radiological Science, School of Medicine, Chang Gung University

 

Employment record:    
1/2013 Chairman, Cancer Committee, Chang Gung Memorial Hospital
1/2010 – 12/2012    Director of Cancer Center, Chang Gung Memorial Hospital
1/2004 - present   Vice director of Cancer Center, Chang Gung Memorial Hospital
1/2000 – 2003/12    Director of Cancer Center, Chang Gung Memorial Hospital
10/1997 - present    Director, Department of Radiation Oncology,
Chang Gung Memorial Hospital
7/1995     - 10/1997 Attending physician, Department of Radiation Oncology, Chang Gung Memorial Hospital
4/1995 - 6/1995       Post-doctor in Department of Radiation Oncology, Experimental Division, UCLA
7/1991 - 3/1995       Research Assistant in Department of Radiation Oncology, Experimental Division, UCLA
7/1988 - 8/1990       Attending physician, Department of Radiation Oncology, Chang Gung Memorial Hospital
7/1984 - 6/1988       Resident and Chief resident, Department of Radiation Oncology, Chang Gung Memorial Hospital
6/1977 - 6/1984       Rotating internship, Chang Gung Memorial Hospital

專長

Specialty

輻射及腫瘤生物研究

Radiation and Cancer Biology

婦科腫瘤、攝護腺腫瘤、淋巴瘤、肝癌、消化系統癌症

Gynecological cancer, Genitourinary cancer, Gastrointestinal cancer.

參與學會

Membership in Scientific and Medical Societies

American Association of Cancer Research (AACR)
American Society for Therapeutic Radiology and Oncology (ASTRO)
Taiwan Society for Therapeutic Radiology and Oncology
Chinese Society for Medical Physics
International Gynecologic Cancer Society (IGCS)
Radiation Research Society (RRS)

Radiological Society of R.O.C

發表論文

Publications: (*Corresponding author)
more than 115 peer-reviewed papers and only list those published after 2007 

  1. D. L. Tsan, K. H. Fan, Y.C. Chen, C. K. Chuang, C. C. Lee and J.H. Hong*Pre-radiotherapy PSA level as a predictor for biochemical control in prostate cancer patients receiving radiotherapy after radical prostatectomy. Biomed J.,  2013,  36:71-6
  2. Y. C. Lin, J. J. Wang, J. H. Hong, Y. P. Lin, C. C. Lee, Y. Y. Wai, S. H. Ng, Y. M. Wu, C. C. Wang  Noninvasive monitoring of microvascular changes with partial irradiation using dynamic contrast-enhanced and blood oxygen level-dependent magnetic resonance imaging. Int. J. Radiat. Oncol. Biol. Phys., 2013, 85:1367-74 (SCI)
  3. P.F. Tsai, S. M. Lin, S. H. Lee, C. Y. Yeh, Y. T. Huang, C. C. Lee, J. H. Hong* The feasibility study of using multiple partial volumetric-modulated arcs therapy in early stage left-sided breast cancer patients. J Appl Clin Med Phys. 2012 13:3806.  doi: 10.1120/jacmp.v13i5.3806. (SCI)
  4. J. J. Chen, S. Y. Fu, C. S. Chiang, J. H. Hong and C. K. Yeh Characterization of tumor vasculature distribution in centeral and peripheral regions based on doppler ultrasound.  Med. Phys, 2012,  39,7490-7498 (SCI)
  5. C. C. Wang, C. H. Lai, Y. T. Huang, A. C. Chao, H. H. Chou and J. H. Hong*  HPV genotypes predict survival benefits from concurrent chemotherapy and radiation therapy in advanced squamous cell carcinoma of the cervix.  Int. J. Radiat. Oncol. Biol. Phys., 2012, 84:e499-506  (SCI)
  6. C. T. Wu, C. C. Hsieh, C. C. Lin, W. C. Chen, J. H. Hong and M. F. Chen  Significance of IL-6 in the transition of hormone-resistant prostate cancer and the induction of myeloid-derived suppressor cells.  J Mol Med (Berl). 2012, 90:1343-55 (SCI)
  7. Y. T. Huang, C. C. Wang, C. S. Tsai, C. H. Lai, T. C. Chang, H. H. Chou,. P. Lee and J. H. Hong*  Clinical behaviors and outcomes for adenocarcinomas or adenosquamous carcinomas of cervix treated by radical surgery and adjuvant radiotherapy or chemoradiotherapy. Int. J. Radiat. Oncol. Biol. Phys., 2012, 84: 420-427 (SCI)
  8. K. H. Fan, Y. C. Chen,  W. M. Leung, C. K. Chuang, S. T. Pang and  J. H. Hong*, Adjuvant and Salvage Radiotherapy for Urothelial Cell Carcinoma of Upper Urinary Tract: A Single Institute Experience. Chang Gung Med. J. 2012, 35: 247-254
  9. S. C. Wang, J. H. Hong, C. Hsueh, and C. S. Chiang Tumor-secreted SDF-1 promotes glioma invasiveness and TAM tropism toward hypoxia in a murine astrocytoma model. Lab Invest. 2012, 92: 151-162  (SCI)
  10. K. C. Ho, C. C. Wang, J. T. Qiu, C. H. Lai, J. H. Hong, Y. T. Huang, K. G. Huang, A. Chao, G. lin and T. C. Yen  Identification of prognostic factors in patients with cervical cancer and supraclavicular lymph node recurrence, Gynecol. Oncol. 2011, 123: 253-256 (SCI)
  11. F. H. Chen, C. S. Chiang, C. C. Wang, S. Y. Fu, C. S. Tsai, S. M. Jung, C. J. Wen, C. C. Lee, and J. H. Hong* Vasculatures in Tumors Growing from Preirradiated Tissues: Formed by Vasculogenesis and Resistant to Radiation and Antiangiogenic Therapy. Int. J. Radiat. Oncol. Biol. Phys., 2011,  80: 1512-1521 (SCI)
  12. J. J. Chen, J, J. Jason Chen, C. S. Chiang, J. H. Hong, C. K. Yeh Assessment of tumor vasculature for diagnostic and therapeutic applications in a mouse model in vivo using 25-MHz power Doppler imaging, Ultrasonics, 2011, 51: 925-931 (SCI)
  13. Y. T. Huang, C. C. Wang, C. S. Tsai, C. H. Lai, T. C. Chang, H. H. Chou, S. Hsueh, C. K. Chen, S. P. Lee and J. H. Hong*  Long term outcome and prognostic factors for adenocarcinoma/adenosquamous carcinoma of cervix after definite radiotherapy. Int. J. Radiat. Oncol. Biol. Phys., 2011,  80: 429-436 (SCI)
  14. S. C. Wang, C. C. Wu, Y. Y. Wei, J. H. Hong, C. S. Chiang  Inactivation of ataxia telangiectasia mutated gene can increase intracellular reactive oxygen species levels and alter radiation-induced cell death pathways in human glioma cells. Int J Radiat Biol. 2011, 87:432-42 (SCI)
  15. L. H. Hsu, Y. P. Chen, H. P. Chang, Y. R. Chen, J. H. Hong, A. Chao, C. H. Successful salvage treatment of recurrent endometrial cancer with multiple lung and abdominal metastases. Eur J Gynaecol Oncol. 2011;32:218-20 (SCI)
  16. W. C. Cheng, M. L. Tsai, C. W. Chang, C. L. Huang, C. R. Chen, W. Y. Shu,Y. S. Lee, T. H. Wang, J. H. Hong, C. Y. Li and I. C. Hsu. Microarray meta-analysis database (M(2)DB): a uniformly pre-processed, quality controlled, and manually curated human clinical microarray database.  BMC Bioinformatics. 11:421, 2010 (SCI)
  17. H. H. Chou, H. P. Chang, C. H. Lai, K. K. Ng, S. Hsueh, T. I. Wu, M. Y. Chen, T. C. Yen, J. H. Hong and T. C. Chang 18F-FDG PET in stage IB/IIB cervical adenocarcinoma/adenosquamous carcinoma. Eur J Nucl Med Mol Imaging. 37: 728-735, 2010 (SCI)
  18. C. C. Wang, C. H. Lai, H. J. Huang, A. Chao, C. J. Chang, T. C. Chang, H. H. Chou and J. H. Hong* Clinical Impact of Human Papillomavirus Genotypes in Patients with Cervical Cancer Undergoing Primary Radiotherapy.  Int. J. Radiat. Oncol. Biol. Phys.,  78: 1111-1120, 2010 (SCI)
  19. C. S. Tsai, C. H. Lai, T. C. Chang, T. C. Yen,  K. K. Ng, S. Hsueh, and J. H. Hong*A prospective randomized trial to study the impact of pre-treatment FDG-PET for cervical cancer patients with positive pelvic nodes but negative para-aortic node shown on MRI .  Int. J. Radiat. Oncol. Biol. Phys., 76: 477-484, 2010 (SCI)
  20. F. Y. Liu, T. C. Yen, M. Y. Chen, C. H. Lai, T. C. Chang, H. H. Chou, J. H. Hong, Y. R.Chen and K. K. Ng  Detection of hematogenous bone metastasis in cervical cancer: 18F-fluorodeoxyglucose-positron emission tomography versus computed tomography and magnetic resonance imaging.  Cancer, 115: 5470-5480, 2009 (SCI)
  21. K. H. Fan, Y. C. Chen, C. K. Chuang, M. L. Hsieh and J. H. Hong*: Adjuvant androgen deprivation therapy loses its therapeutic benefit after premature termination: an experience of combined modality treatment on prostate cancer. Chang Gung Med. J. 32: 526-534, 2009
  22. T. M. Huang, J. H. Hong, W. M. Leung, C. Y. Lin, D. L. Tsa and N. M. Tsang Radiation therapy for advanced hepatocellular carcinoma with hepatic hilum involvement and high bilirubin level: better survival in decreased bilirubin after radiotherapy.  Therapeutic Radio. Oncol. (R. O. C.), 16: 179-194, 2009
  23. D. I. Tsan, J. H. Hong, N. M. Tsang, C. H. Chen and S. Y. Lin : Treatment outcome and pattern of failure in patients with Hodgkin’s lymphoma treated with radiotherapy: a single institution’s experience.  Therapeutic Radio. Oncol. (R. O. C.), 16: 85-97, 2009
  24. T. C. Chao, A. M. Chen, S. J. Tu, C. J. Tung, J. H. Hong and C. C. Lee   Evaluation of 6 and 18 MeV electron beams for small animal iirradiation.  Phys. Med. Biol.,  54: 5847-5860, 2009 (SCI)
  25. M. H. Lin, T. C. Chao, C. C. Lee, C. J. Tung, C. Y. Yeh and J. H. Hong Measurement-Based Monte Carlo Dose Calculation System for IMRT Pre-treatment and In-vivo Dose Verifications.  Med. Phys, 36:1167-75, 2009 (SCI)
  26. F. H. Chen, C. S. Chiang, C. C. Wang, C. S. Tsai, S. M. Jung, C. C. Lee, W. H. McBride, and J. H. Hong*: Radiotherapy decreases vascular density and causes hypoxia with macrophage aggregation in TRAMP-C1 prostate tumors.  Clin. Cancer Res. 15:1721-1729, 2009 (SCI)
  27. W. C. Liu, W. L. Chuang, M. L. Tsai, J. H. Hong, W. H. McBride and C. S. Chiang.  Cordyceps sinensis health supplement enhances recovery from Taxol-induced leucopenia.  Exp. Biol. Med., 233:447-455, 2008 (SCI)
  28. A. Chao , T. H. Wang, Y. S. Lee, J. H. Hong, C. N. Tsai , C. K.Chen, C. S. Tsai, A. S. Chao, C. H. Lai.  Analysis of functional groups of differentially expressed genes in the peripheral blood of patients with cervical cancer undergoing concurrent chemoradiation treatment. Radiat Res. 169:76-86, 2008 (SCI)
  29. C. S. Chiang, F. H. Chen, J. H. Hong, P. S. Jiang, H. L. Huang, C. C. Wang and W. H. McBride: Functional phenotype of macrophages depends on assay procedures, Int. Immunology, 20:215-22. 2008 (SCI)
  30. T. C. Yen, L. C. See , C. H. Lai, C. S. Tsai, A. Chao, S. Hsueh, J. H. Hong, T. C. Chang and K. K. Ng. Standardized uptake value in para-aortic lymph nodes is a significant prognostic factor in patients with primary advanced squamous cervical cancer. Eur J Nucl Med Mol Imaging. 35:493-501, 2008 (SCI).